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Background. With modern CT imaginga comprehensive overview of cerebral macro- andmicrocirculation can be obtained within
minutes in acute ischemic stroke. This opens for patient stratiﬁcation and individualized treatment. Methods. Four patients with
a c u t ei s c h e m i cs t r o k eo fd i ﬀerent aetiologies and/or treatments were chosen for illustration of the comprehensive CT protocol
and its value in subsequent treatment decisions. The patients were clinically evaluated according to the NIHSS-scale, examined
with the comprehensive CT protocol including both CT angiography and CT perfusion, and followed up by MRI. Results.T h e
comprehensive CT examination protocol increased the examination time but did not delay treatment initiation. In some cases CT
angiography revealed the cause of stroke while CT perfusion located and graded the perfusion defect with reasonable accuracy,
conﬁrmed by follow-up MR-diﬀusion. In the presented cases ﬁndings of the comprehensive CT examination inﬂuenced the
treatment strategy. Conclusions. The comprehensive CT examination is a fast and safe method allowing accurate diagnosis and
making way for individualized treatment in acute ischemic stroke.
1.Introduction
Current guidelines for treatment of acute stroke by intra-
venous (IV) thrombolysis with recombinant tissue-type
plasminogen activator (rt-PA) [1, 2]a r eb a s e do ns e v e r a l
large trials showing favorable results for this treatment
within the 3- or 4.5-hour time window [3–9]. The main lim-
itation has been the diminished beneﬁt of IV-thrombolytic
treatment beyond the given time frame. However, in these
trials, the diagnosis of acute stroke was made clinically
with supplementary nonenhanced computer tomography
(NECT) examination to exclude intracranial hemorrhage
and extensive early ischemic changes, both considered
contraindications for thrombolytic treatment. No perfusion
measurements or angiographic studies were carried out,
which might have allowed treatment individualization and
improved treatment results.
Clinical evaluation and NECT examination are still the
most important toolsinthe workupofacuteischemic stroke.
With modern brain CT-imaging, a supplementary overview
of cerebral macro- and microcirculation can be obtained
in minutes with CT angiography (CTA) and CT perfusion,
providing valuable information before or during treatment
initiation.
The aim of this study was to illustrate a comprehensive
three-step CT imaging protocol for acute stroke consisting
of NECT to exclude hemorrhage and other contraindica-
tions for IV-thrombolysis, contrast enhanced dynamic CT-
perfusion scan (CTP) to evaluate the existence and grade
of perfusion deﬁcit, and ﬁnally a contrast enhanced CT-
angiography(CTA)ofthecervicalandintracranialarteries to
locate and grade possible arterial occlusions. We describe the
comprehensive radiological examination and evaluation and
discussthetimeaspectandpresentclinicalcasesemphasizing
and discussing the impact of the method on treatment
individualization.
2.Methodsand Material
Four patients with acute ischemic stroke of diﬀerent aeti-
ologies or diﬀerent treatments were chosen for illustration2 Stroke Research and Treatment
Table 1: Overview of starting times of relevant events and NIHSS scores for the four diﬀerent cases.
Event Case 1 Case 2 Case 3 Case 4
Onset of symptoms 0 0 0 0+
Arrival at the stroke center 14min 38min 38min 4h 0min
NIHSS evaluation 14 9 14 11
CT -head 43min 56min 54min 4h25min
CT-perfusion 47min 63min 64min 4h 41min
CT-angiography 51min 66min 68min 4h 53min
IV-thrombolysis 65min 80min — —
Thrombectomy/IA-thrombolysis 210min — — 6h 30min
NIHSS evaluation at discharge 16 0 1
of the comprehensive CT protocol and for demonstrating
the impact of the information obtained on treatment
decisions.
When the ﬁrst medical personnel arrived at the scene
of a suspected acute stroke they immediately notiﬁed the
stroke center. In this way the patients entered the stroke
fast-track service before physically arriving at the hospital,
giving the hospital stroke team, consisting of personnel from
the emergency department, a neurologist and the radiology
department personnel, time to prepare and coordinate their
actions. The neurological deﬁcit was quantiﬁed using the
National Institutes of Health Stroke Scale (NIHSS) [10]a n d
the patients were immediately transferred to the radiology
department where they entered the three-step comprehen-
sive CT examination performed using a Brilliance 64-slice
CT (Philips Medical Systems, Best, The Netherlands).
Firstly a spiral whole-brain NECT was performed
with 16×1.0mm primary slices (120kV, 355mAs, CTDI
57mGy=2.2mSv) reconstructed to axial and coronal MPR
with 5 and 3mm slice thickness, respectively, to rule
out intracranial hemorrhage and early imaging ﬁndings
of ischemia, both representing contraindications for intra-
venous thrombolysis.
If no contraindications for IV thrombolysis were estab-
lished, dynamic contrast-enhanced CTP was performed
with injection of 70mL Iomeprol 400mgI/mL (Iomeron,
Bracco SA, Milano, Italy) followed by 40mL saline injected
at 5mL/sec. A total of 34 sequential acquisitions were
performed with a scan interval of 1.5 seconds covering
a 4cm-thick section of the brain (80kV, 170mAs, CTDI
5.9mGy/scan×34 scans=200mGy=1.7mSv). Each acqui-
sition consisted of eight adjacent 5mm slices covering 4cm
of brain extending upwards from a level 2cm above the
entrance of the sella. Brain perfusion analysis was performed
using the brain perfusion package of the Extended Brilliance
Workspace(PhilipsMedicalSystems,Best,TheNetherlands).
For the arterial input and venous output functions the A2
segment of the anterior cerebral artery and the posterior
superior sagittal sinus were used respectively, avoiding
occludedarteriesorothermajorabnormalities[11].Cerebral
blood volume (CBV), cerebral blood ﬂow (CBF), and mean
transit time (MTT) were calculated and displayed by the
software. The software packageprovided an automated color
coded CTP-viability map. The penumbra (tissue at risk) was
deﬁned as a region where MTT was prolonged by more
than 50% when compared to the contralateral hemisphere
[12] and was indicated by green color. The infarct core
w a sd e ﬁ n e da sar e g i o nw i t h i nt h ep e n u m b r aw h e r eC B V
measured lower than 2mL/100g and was indicated by red
color (Figure 1).
Finally a contrast-enhanced CTA of the cervical and
intracranial arteries was performed with 64×1.0mm pri-
mary slices (120kV, 225mAs, CTDI 943mGy=4.6mSv) in
one continuous run after the administration of 100mL
Iomeprol 400mgI/mL followed by 40mL saline injected at
5mL/sec. The CTA scan was started by automated monitor-
ing of the contrast enhancement in the descending aorta.
Reconstructions were created with 3mm-slice thickness in
theaxial,sagittalandcoronalplanesinadditiontomaximum
intensity projections (MIP)and three-dimensional images in
selected cases.
The eﬀective dose for each examination was estimated
f r o mt h ed o s el e n g t hp r o d u c t( D L P )b yt h ee q u a t i o nE
[mSv]=DLP×f. The conversion factor (f)u s e df o rN E C T
and CTP was 0.0021and 0.0049forCTA [13].All stated dose
values are the typical dose values of our standard protocols.
Slight individual dose variation occurs due to diﬀerent scan
lengths and the use of dose modulation.
The imaging information was reviewed directly at the
workstation during the examination and immediate treat-
m e n td e c i s i o n sw e r em a d eb yaj o i n te ﬀort of the neu-
rologist and the neuroradiologist. For intravenous throm-
bolysis 0.9mg/kg alteplase (Actilyse) was administered by
IV-infusion over 60 minutes (maximum 90mg). Patients
selected forneurointerventionaltreatment underwentdigital
subtraction angiography (DSA) followed by intraarterial
(IA) thrombolysis and/or mechanical thrombectomy. Time
of important events was accurately logged throughout
the whole process, from onset of symptoms to treatment
initiation (Table 1).
For followup the patients underwent a magnetic reso-
nance imaging (MRI) examination within 48 hours from
symptom onset. The examinations, performed on a Philips
Intera (Philips Medical Systems, Best, The Netherlands) or
Siemens Allegra (Siemens Medical, Munich, Germany) 3
Tesla scanners, included T1, T2, FLAIR, diﬀusion weighted
imaging (DWI), and in selected cases MR perfusion (MRP)
and time-of-ﬂight MR-angiography (MRA).Stroke Research and Treatment 3
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Figure1:Case1:66-year-oldmalewithleft-sidedstrokesymptomsandanormalNECT. Initialcomprehensiveexaminationshowsreduction
of both CBF and CBV in the right hemisphere and an increase in MTT caused by a right-sided M2-segment MCA occlusion(arrow) seen on
the CTA. The CTP viability map shows a small area of advanced perfusion defect (red) in the right hemisphere surrounded by a relatively
large penumbra (green).
3.Results
3.1. Case 1: CTP Results Change Treatment Strategy. 66-
year old male with hypertension and controlled hyper-
cholesterolemia presented with acute onset of left-sided
weakness and diﬃculty speaking. On physical examination
he was fully-oriented but had dysarthria, rightward gaze
preference, left sided hemiparesis involving the face, and left
sensory deﬁcits. The NIHSS score was 14 (Table 1). NECT
was normal, but CTP showed a small area of advanced
perfusion deﬁcit with a relatively large surrounding area
of potentially salvageable ischemic brain tissue (penumbra)
in the arterial territory of the right insular artery. This
was conﬁrmed by the visualization of an M2 segment
occlusion of the right middle cerebral artery (MCA) on
CTA (Figure 1). IV thrombolysis was initially given but
since the treatment did not lead to any signiﬁcant change in
symptoms theCTexamination wasrepeated.ThenewNECT
showed early signs of infarction in the right basal ganglia.
CTP showed unchanged ischemic core size but marked
enlargement of the surrounding penumbra (Figure 2). Based
on the ﬁndings of penumbra progression despite treatment
with IV-thrombolysis, implicating worsening prognosis, the
patient underwent DSA which showed an embolic occlusion
of the right insular artery. After unsuccessful attempt at
thrombectomy, local IA thrombolysis was started leading
to complete dissolution of the embolus within 5 hours
from the onset of symptoms (Figure 3). Right after the
neurointervention the patient scored 12 on NIHSS, and
the next day the NIHSS score was down to 4 with only4 Stroke Research and Treatment
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Figure 2:Case1:Repeated NECT and CTP examinations90 minutes after IV-thrombolysiswithoutclinical improvement.The NECT is still
normal and the CTP shows unchanged ischemic core but moderate enlargement of the penumbra. Based on this information the patient
underwent intraarterial thrombolysis.
slightremaining left-sidedweakness. Follow-upMRIshowed
diﬀusion abnormality in the right putamen corresponding
to the CT-perfusion deﬁned ischemic core, but normal
perfusion in the CT-deﬁned penumbra region (Figure 4).
One week after initial presentation the NIHSS score was 1
and the patient was discharged with only minor strength
reduction in the left arm and a partial central facial
paresis.
3.2. Case 2: Fragmented Cardiogenic Embolism. 65-year-old
male with controlled hypertension and paroxysmal atrial
ﬁbrillation who presented with acute onset of left-sided
weakness and diﬃculty speaking the day after electrical
deﬁbrillation. On physical examination he was fully oriented
but had general left-sided hemiparesis, facial weakness, mild
dysarthria and hemi-inattention (neglect) to more than one
sensory modality and scored 9 on NIHSS (Table 1). NECT
wasnormal,butCTP showed multiplesmall areas ofreduced
perfusion (penumbra) in the right hemisphere with a small
area of advanced ischemic core anterior to the Sylvian ﬁssure
(Figure 5). CTA showed no deﬁnitive arterial occlusion.
After treatment with IV-thrombolysis the NIHSS score was
down to 5 with only slight remaining left-sided weakness
and minor sensory loss. Follow-up MRI showed diﬀusion
abnormality in the right frontal lobe immediately anterior
to the Sylvian ﬁssure conﬁrming the CT-perfusion deﬁned
infarct, but showed no additional diﬀusion- or perfusion
abnormalities (Figure 6). The patient was transferred to a
rehabilitation center.
3.3. Case 3: Lacunar Stroke with Spontaneous Recovery. 49-
year-old male with uncontrolled hypertension presented
with acute onset of right-sided weakness and diﬃculty
speaking. On physical examination he was fully oriented but
had dysarthria and right-sided hemiplegia including facial
nerve palsy but no sensory deﬁcits. The NIHSS score was
14 (Table 1). NECT and CTA were normal, but the CTP
showed a small perfusion defect in the left corona radiata
that was initially missed (Figure 7). Just before planned
administration of IV-thrombolysis the patient’s symptoms
spontaneously and completely resolved and the treatment
was cancelled. Shortly thereafter the patient experienced
transient relapse of the initial symptoms lasting about 5
minutes, again with complete recovery. Follow-up MRI
conﬁrmed an acute lacunar infarction in the left corona
radiata matching the subtle CTP perfusion deﬁcit (Figure 8).
On the third day the patient was discharged with no
persisting neurological deﬁcit.Stroke Research and Treatment 5
After intervention
During intervention
Figure 3: Case 1: DSA images from the right anterior cerebral
circulation. The microcatheter is seen in an occluded M2-segment
of the right MCA (arrow) during the intervention. The IA-
thrombolysis results in complete recanalization of the occluded
segment.
ADC DWI FLAIR
Figure 4: Case 1: follow-up MRI with FLAIR, DWI and ADC
showing an established infarction in the right basal ganglia region,
withminorhemorrhagictransformation,corresponding well to the
previously deﬁned CTP ischemic core.
3.4. Case 4: Fluctuating Symptoms and Unknown Time of
Onset. 27-year-old woman using oral contraceptives and
withpriorhistoryofmigraineandbenignchildhoodepilepsy
wokeupwithﬂuctuatingleft-sidedweakness. Priortoadmis-
sion she experienced 5 episodes of weakness each lasting 5–
10 minutes and followed by near-complete recovery. NECT,
CTA, and CT venography (CTV) performed at a local hospi-
tal were judged normal. In retrospect a dense media sign was
seen on the NECT and an occlusion of the right MCA M2-
segment on the CTA. The patient was referred to the stroke
center and upon arrival she was fully oriented but physical
examination revealed left sided hemiplegia and facial nerve
palsy. The current symptom episode had persisted for
over 1 hour without any recovery, unlike the previous
attacks. Her NIHSS score was 11 (Table 1). Repeated NECT
was normal but CTP showed a large volume of ischemic
brain tissue in the right basal ganglia and frontal lobe,
without evidenceof advanced perfusion deﬁcit. CTA showed
unchangedocclusionofarightMCAM2-segment(Figure9).
An acute MRI examination with DWI showed two small
right sidedischemic lesions within theCTP-deﬁned ischemic
area (Figure 10). Since the duration of symptoms was more
than 4.5 hours, it was decided to perform IA-thrombolysis.
DSA conﬁrmed the M2-occlusion which was completely
recanalized by local IA-thrombolysis within 6 hours from
onset of persistent neurological symptoms (Figure 11). The
intervention was performed with the patient awake. During
the treatment a partial revascularization was established
and the patient instantly became capable of moving her
previously paretic left extremities. Intraarterial thrombolysis
was then stopped despite a remaining thrombus because of
therisk thatfurther lysiswouldincrease therisk ofsecondary
hemorrhage. The patient complained of increasing headache
and a follow-up NECT demonstrated a small hemorrhagic
transformation in the right basal ganglia region measuring
10×12mm (Figure 12). She was left with persisting partial
facial paresis resulting in a NIHSS score of 3. Follow-up
MRI including MR-angiography showed slight enlargement
of the two known diﬀusion abnormalities located in the
right basal ganglia and centrum semiovale with complete
revascularization of the right MCA (Figure 12). No progress
of the hemorrhagic component was noted. One week after
initial presentation the NIHSS score was 1 and the patient
was transferred back to the local hospital.
4.Discussion
4.1. The Comprehensive Acute Examination. According to
current guidelines all patients with suspected acute ischemic
stroke receive the same treatment within the given time
frame, regardless of imaging ﬁndings which potentially
might be used to individualize treatment.
A negative comprehensive CT examination does not
exclude patients with clinically suspected acute ischemic
stroke from receiving IV thrombolysis because symptomatic
small vesselocclusions(Case3)can bediﬃcult to detectboth
on CTA and CTP. On the contrary a positive comprehensive
CT examination can be valuable when choosing the optimal
treatment. Whenalarge vesselocclusionisidentiﬁed onCTA
(Cases 1 and 4) an evaluation of the collateral circulation
in the aﬀected territory with CTP can be useful to identify
patients with perfusion mismatch suggesting tissue at risk
that might be salvaged. These patients should be considered
for IV-thrombolysis but the treatment can be converted to
IA thrombolysis (bridging) for more aggressive approach if
needed, potentially increasing the chance of a good outcome6 Stroke Research and Treatment
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Figure 5:Case2:65-year-old maleleft-sided strokesymptomsanda normalNECT. The CTP viabilitymapshowsmultipleperfusion defects
(green) and a small area of advanced perfusion deﬁcit (red) in the right hemisphere consistent with fragmented cardiogenic embolism. The
CTA showed no major arterial occlusion obviating neurointervention.
ADC DWI FLAIR
Figure 6: Case 2: follow-up MRI with FLAIR, DWI, and ADC
showingan established infarction in the right frontallobe matching
the CTP-delineated ischemic core.
asincase1[14–16].Resultsfrommeta-analysis haveshown a
recanalization rate for IV-thrombolysis of about 46%, while
IA-thrombolysis and mechanic thrombectomy have recanal-
ization rates of about 63% and 84%, respectively, [17].
Moreover the information from the CTP might intro-
duce some ﬂexibility to the currently ﬁxed therapeutic time
window and increase safety when the time of onset is
unknown (Case 4).
R e c e n t l yt h et i m ef r a m ef o rt r e a t m t e n tw i t hI Vt h r o m -
bolysis was extended from 3 hours after symptom onset
[3–7]t o4 . 5h o u r s[ 8, 9] ,w h i l et h et i m ef r a m ef o rI A
thrombolysis remains 6 hours after symptom onset [18, 19].
In some instances the CTP can reveal the underlying
pathological process as in case 2 where the patient had
multiple small ischemic regions in both the anterior and
posterior circulation consistent with fragmented cardiac
emboli without major vessel occlusion, excluding treatment
with thrombectomy or IA thrombolysis.Stroke Research and Treatment 7
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Figure 7: Case 3: 49-year-old male with right sided stroke symptoms and a normal NECT. The CTP source images show a small perfusion
deﬁcit in the left corona radiata with a marked decrease of both CBF and CBF (circle) that was initially missed by both the radiologist and
the automated viability map software. CTA was normal.
ADC DWI FLAIR
Figure 8: Case 3: Follow-up MRI with FLAIR, DWI and ADC
showing a small lacunar infarction in the right corona radiata that
is also seen retrospectively on the CTP maps (Figure 7).
Still studies on the clinical application of CTP results are
lacking so even though the comprehensive CT examination
is promising in many ways the impact of the method on the
clinical outcome is yet unknown.
4.2. MRI versus CT in Acute Ischemic Stroke. DWI/MRP
is currently the gold standard for infarct evaluation in
acute ischemic stroke because of the superiority of DWI in
assessing tissue viability [20, 21], despite some disadvantages
and pitfalls [22]. CTP provides useful information about the
existence and grade of perfusion deﬁcit providing equivalent
information to the combined MR DWI, ADC, and MRP
sequences [23]. Furthermore it has been shown that CTP
can distinguish salvageable penumbra from nonsalvageable
ischemic core with good correlation with follow-up DWI
[12, 23, 24]. CTA provides information about the location
of large arterial occlusion and is helpful in deciding on a
therapeutic approach with IV or IA thrombolysis, and/or
thrombectomy.8 Stroke Research and Treatment
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Figure 9: Case 4: 27-year-old woman with left-sided stroke symptoms of unknown onset and a normal NECT. The CTP viability map
showed no ischemic core but a relatively large penumbra (green) in the right basal ganglia caused by a M2-segment MCA occlusion(arrow)
seen on the CTA.
Using perfusion data to assess tissue viability as in
CTP is inherently inaccurate because the result of disturbed
perfusion is both tissue- and time-dependent. The color
coded infarct core (red) and surrounding penumbra (green)
inCTP-viabilitymapsisthereforemerelyaroughestimateon
the current status of a dynamic process [11]. Part of the CTP
infarct core might prove to be viable tissue if the blood ﬂow
is quickly restored and part of the penumbra may become
infarcted later in the process.
Nevertheless, CTP has over the last years gained accep-
tanceasanalternativeexaminationtoDWI/MRPintheacute
phase of ischemic stroke, mostly because of technical and
practical advantages. It oﬀers faster examination time and
more eﬀective workﬂow since it can be done in continuity
with the standard NECT examination. It has been estimated
that approximately 1.9 million neurons are lost every minute
following the occlusion of a major cerebral artery [25].
Fast radiological diagnosis is essential for early treatment
initiation. If everything runs smoothly the complete radio-
logical examination described in this paper takes less than
10 minutes including a preliminary evaluation, which is in
agreement with other authors [23], and it does not delay
treatment initiation because the two are carried out as
parallel processes.
Additionally CTP is more robust than MRP because it
oﬀers quantitative measurement of perfusion with higher
spatial resolution and a linear relationship between contrast
concentration and attenuation [26]. This together with
shorter examination time, greater availability, and lower cost
makes CTP an attractive method in the acute setting in cases
where IA thrombolysis is a possible treatment option.
Until recently a major disadvantage of CTP has been the
limited coverage of the examination whereas DWI covers the
whole brain. Common CTP techniques oﬀer only 4–8cmStroke Research and Treatment 9
ADC DWI FLAIR
Figure 10: Case 4: acute MRI with FLAIR, DWI and ADC showing
an established infarction in the right basal ganglia that was not
detected by the CTP examination.
During thrombolysis
Before thrombolysis
Figure 11: Case 4: DSA images from the right anterior cerebral
circulation before recanalization showed an occluded right MCA
M2-segment. During IA-thrombolysis partial revascularization was
achieved with a remaining clot.
coverage, with the risk of small peripheral ischemic lesions
being missed. This problem has now been overcome with
the availability of 320 slice MDCT with 16cm coverage [27].
Extended CTP coverage and increased sampling frequency
linearly increases the radiation dose. The estimated eﬀective
dose equivalent of the comprehensive acute stroke protocol
described in this paper amounts to 8.5mSv (2.2+1.7+4.6)
which is in agreement with otherstudies [28] and reasonable
considering the added value for treatment individualization
in this serious acute disease. Only 20% of the total eﬀective
dose in the comprehensive protocol can be attributed to the
CTP examination.
MR angiography NECT
ADC DWI FLAIR
Figure 12:Case4:follow-upMRIwith FLAIR,DWI,ADCshowing
a relatively small infarction with minor hemorrhage in the right
basal ganglia in comparison to the large penumbra seen on the
initial CTP examination. The MRA shows complete recanalization
of the previously partially revascularized right MCA. NECT shows
a small hemorrhagic transformation in the right basal ganglia
and parenchymal contrast leakage due to increased permeability
secondary to ischemia and neurointervention.
Interpretation of the DWI images in ischemic stroke
is generally simple. Misinterpretation of data in CTP can
be an obstacle for the novice reader, particularly when
relying overly on the computer generated viability map. The
CTP software used in our study automatically generates
a viability map by comparing the two hemispheres and
searching for asymmetric perfusion. Therefore, the software
does not detect bilateral symmetric lesions for example in
patients with older lesions in the contralateral hemisphere.
Furthermore, to reduce noise, the viability map has a size
threshold preventing automatic detection of tiny lesions
(case 3). Misinterpretation can be avoided by understanding
and thoroughly reviewing the basic perfusion images and
comparing them with theanatomical images from theNECT
and CTA.
When NECT is used as the only radiological base for
treatment decision in clinically suspected acute ischemic
stroke, it may in some cases be unclear what pathophysio-
logical process actually is being treated. The comprehensive
CT examination aims at guiding stroke management in the
acute setting, possibly allowing for patient stratiﬁcation and
individualized treatment strategies with improved clinical
outcome.
5.Conclusion
This extended case review shows the potential of combined
NECT, CTP and CTA as a fast and safe diagnostic method
allowing more accurate diagnosis and making way for early
individualized treatment in acute ischemic stroke. However,10 Stroke Research and Treatment
the method has not yet been systematically evaluated in
studies with high evidence class.
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